SWITCH PATTERNS AND TOTAL COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIASIS

被引：0
|
作者：
Wu, J. [1 ]
Pelletier, C. [2 ]
Ung, B. [2 ]
Tian, M. [2 ]
Ni, Q. [2 ]
Curtis, J. R. [3 ]
机构：
[1] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
[2] Celgene Corp, Summit, NJ USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.2523
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS23
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [21] Effectiveness and safety of apremilast in biologic-naive patients with moderate psoriasis treated in routine clinical practice in Greece: the APRAISAL study
    Ioannides, D.
    Antonakopoulos, N.
    Georgiou, S.
    Chasapi, V
    Katsantonis, I
    Drosos, A.
    Rigopoulos, D.
    Antoniou, C.
    Anastasiadis, G.
    Bassukas, I
    Ioannidou, D.
    Protopapa, A.
    Neofotistou, O.
    Krasagakis, K.
    Aronis, P.
    Papageorgiou, M.
    Lazaridou, E.
    Patsatsi, A.
    Lefaki, I
    Roussaki-Schulze, A., V
    Satra, F.
    Anagnostopoulos, Z.
    Papakonstantis, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (09) : 1838 - 1848
  • [22] ANALYSIS EFFICACY OF ABATACEPT TREATMENT IN BIOLOGIC-NAIVE AND BIOLOGIC-EXPERIENCED PATIENTS.
    Borisova, M.
    Lukina, G.
    Yakov, S.
    Luchikhina, E.
    Karateev, D.
    Novikov, A.
    Aleksandrova, E.
    Aronova, E.
    Glukhova, S.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1300 - 1300
  • [23] Patterns of Care for Biologic-Dosing Outliers and Nonoutliers in Biologic-Naive Patients with Rheumatoid Arthritis
    Delete, Thomas
    Meyer, Roxanne
    Jenkins, Daniel
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (08): : 798 - 808
  • [24] Treatment patterns in the first year for biologic-naive psoriasis patients starting on etanercept and adalimumab in a pharmacy benefit management setting
    Joseph, George J.
    Harrison, David J.
    Thomas, Jessy
    Blume, Steven W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB216 - AB216
  • [25] Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England
    Khalid, Javaria Mona
    Fox, Kathleen M.
    Globe, Gary
    Maguire, Andrew
    Chau, Dina
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2014, 25 (01) : 67 - 72
  • [26] Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL
    Gold, Linda Stein
    Bagel, Jerry
    Lebwohl, Mark
    Jackson, J. Mark
    Chen, Rongdean
    Goncalves, Joana
    Levi, Eugenia
    Duffin, Kristina Collis
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (02) : 221 - 228
  • [27] HEALTH CARE COSTS IN PSORIASIS PATIENTS NEWLY INITIATED ON APREMILAST OR BIOLOGIC THERAPIES
    Feldman, S.
    Kuznik, A.
    Clancy, Z.
    VALUE IN HEALTH, 2016, 19 (03) : A128 - A128
  • [28] Treatment Patterns and Costs in Biologic DMARD-Naive Patients with Rheumatoid Arthritis Initiating Etanercept or Adalimumab with or Without Methotrexate
    Tkacz, Joseph
    Gharaibeh, Mahdi
    DeYoung, Kathryn Henderson
    Wilson, Kathleen
    Collier, David
    Oko-osi, Hafiz
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (03): : 285 - 294
  • [29] Editorial: Is vedolizumab the preferred biologic therapy for biologic-naive patients with ulcerative colitis?
    Yamamoto, Takayuki
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (05) : 546 - 547
  • [30] Persistence and Failure Rates of Monotherapy Etanercept in Biologic-Naive Psoriasis Patients: A Retrospective Study
    Reddy, Shivani P.
    Shah, Vidhi V.
    Lin, Elaine J.
    Egeberg, Alexander
    Wu, Jashin J.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (08) : 1029 - 1030
12345